Related Experiment Videos
Antiplatelets activity of some xanthone derivatives
G Rajtar1, D Zółkowska, Z Kleinrok
1Department of Pharmacology and Toxicology, Medical University School, Lublin, Poland.
Acta Poloniae Pharmaceutica
|January 15, 2000
Summary
Five xanthone derivatives were found to inhibit thrombin-induced platelet aggregation. The most potent compound, R-(+)-2-N-(7-chloro-2-xanthonemethyl)-2-N-methylamino-1-butanol [IV], nearly completely blocked aggregation at 40 micrograms/ml.
Area of Science:
- Pharmacology
- Medicinal Chemistry
Background:
- Platelet aggregation plays a crucial role in thrombosis.
- Xanthone derivatives are being explored for their potential therapeutic properties.
Purpose of the Study:
- To evaluate the anti-platelet aggregation effects of twelve aminoalkanolic xanthone derivatives.
- To identify potent inhibitors of thrombin-induced platelet aggregation.
Main Methods:
- Synthesis and characterization of twelve aminoalkanolic xanthone derivatives.
- In vitro assessment of the compounds' ability to inhibit thrombin-induced platelet aggregation.
Main Results:
- Five of the twelve tested compounds demonstrated significant inhibition of platelet aggregation.
- Compound [IV], R-(+)-2-N-(7-chloro-2-xanthonemethyl)-2-N-methylamino-1-butanol, exhibited the strongest inhibitory activity.
- A concentration of 40 micrograms/ml of compound [IV] nearly completely inhibited thrombin-induced platelet aggregation.
Conclusions:
- Aminoalkanolic xanthone derivatives show promise as anti-platelet agents.
- Compound [IV] is a potent inhibitor of thrombin-induced platelet aggregation and warrants further investigation.